-
Comprehensive Characterization of Early Relapse and End-Stage Relapsed Refractory Multiple Myeloma (HIPO K08K/H067/H021+nonHIPO)
Study
EGAS00001007469
-
Identification of New Therapeutic Targets for Renal Medullary Carcinoma via Integrated Genomic and Transcriptomic Profiling
Study
EGAS50000001280
-
Single cell RNA sequencing of relapsed/refractory multiple myeloma
Study
EGAS00001004805
-
Mutagenic impact of radiotherapy in B-cell lymphoma and multiple myeloma
Study
EGAS50000000997
-
Comprehensive genetic landscape, immune checkpoint profiling, and establishment of patient-derived xenograft (PDX) of metachronous brain tumors from constitutive mismatch repair deficiency with a biallelic variant on MSH6
Study
EGAS50000000351
-
Methylome of medulloblastoma data (MB_COMICS cohort)
Study
EGAS00001007815
-
Drug Perturbation of Primary Lymphoma Patient Samples and RNA Sequencing
Study
EGAS50000001500
-
RNA-seq after drug perturbation of primary lymphoma samples
Dataset
EGAD50000002166
-
PTEN homozygous deletion is a negative prognostic factor in Tumor Treating Fields-treated glioblastoma, IDH wildtype patients
Study
EGAS50000001469
-
Targeted DNA sequencing of TTFields-treated glioblastoma, IDH wildtype
Dataset
EGAD50000002117